...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Eligibility for registered accounts in Canada

I just sent them an email.

 

Ive held some shares in an RRSP since spin-off so they must have some eligibility.

 

We shall see....

 

bfw

Share
New Message
Please login to post a reply